The new approval allows for the 2000mg loading dose to be administered as an IV push rather than a 30-minute IV infusion. The prescribing information for Trogarzo ® (ibalizumab-uiyk) has been updated ...

IRVING, Texas--(BUSINESS WIRE)--Due to the impact to the Baxter International, Inc. North Cove facility in Marion, N.C. from Hurricane Helene, Vizient has published a conservation guide for adult and ...

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14, ...

The approval was based on data from the phase 3 TMB-302 trial that evaluated Trogarzo 800mg administered via IV push once every 2 weeks. The Food and Drug Administration (FDA) has approved Trogarzo ® ...

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14, ...

Hospitals and health systems nationwide are implementing conservation strategies and exploring alternatives to address the national shortage of IV fluids. Hurricane Helene significantly damaged a ...